Endocrinology · Fair Lawn, NJ
NPI
1053421032
Since 2006
Specialty
Endocrinology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
24-07 Broadway
Fair Lawn, NJ, 07410
Phone (201) 796-4600
Groups this clinician bills Medicare through
Medicare paid, 2024
$219K
2,489 services
Medicare patients, 2024
613
Average age 75
Drug cost, 2024
$3.6M
10,938 prescriptions
Company payments, 2025
$12K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Merab Joseph was code 99214 (office e&m - established), 1,242 times for 498 patients. In total Merab Joseph billed 2,489 services in 14 codes, and Medicare paid $219K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,242 | 498 | $101.66 | $126K |
| 99213 Office E&M - Established | Office | 369 | 253 | $70.96 | $26K |
| 95251 Test - Miscellaneous | Office | 302 | 161 | $27.51 | $8,307 |
| 76536 Ultrasound - Nonspecific | Office | 191 | 185 | $90.82 | $17K |
| 95250 Test - Miscellaneous | Office | 133 | 108 | $125.21 | $17K |
| 99204 Office E&M - New | Office | 81 | 81 | $134.98 | $11K |
| 93922 Duplex Scan - Extremity Arteries | Office | 67 | 64 | $68.53 | $4,592 |
| 96401 Chemotherapy Administration | Office | 39 | 14 | $54.92 | $2,142 |
| 99215 Office E&M - Established | Office | 33 | 27 | $142.94 | $4,717 |
By year: 2022 $218K for 2,233 services; 2023 $218K for 2,312 services; 2024 $219K for 2,489 services.
Medicare prescription drug claims, 2024
In 2024, the drug Merab Joseph prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,215 prescriptions and refills. In total Merab Joseph wrote 10,938 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,215 | 2,297 | 256 | $9,952 |
| Ozempic Semaglutide | 670 | 750 | 94 | $678K |
| Jardiance Empagliflozin | 589 | 901 | 125 | $503K |
| Metformin Hcl Generic | 466 | 997 | 124 | $2,907 |
| Metformin Hcl Er Metformin Hcl | 431 | 898 | 118 | $3,945 |
| Humalog Kwikpen U-100 Insulin Lispro | 368 | 602 | 85 | $71K |
| Mounjaro Tirzepatide | 350 | 376 | 60 | $379K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 294 | 556 | 77 | $29K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 263 | 551 | 76 | $26K |
| Novolog Flexpen Insulin Aspart | 258 | 410 | 63 | $45K |
| Rosuvastatin Calcium Generic | 237 | 481 | 66 | $4,749 |
| Glimepiride Generic | 230 | 461 | 62 | $1,667 |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 215 | 349 | 37 | $119K |
| Atorvastatin Calcium Generic | 214 | 439 | 64 | $2,346 |
| Synthroid Levothyroxine Sodium | 211 | 406 | 41 | $15K |
Brand drugs: 5,734 claims; generic drugs: 4,459 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Merab Joseph $12K ($12K in general payments such as food, travel and fees) from 18 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $10K.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $10K |
| Lilly USA, LLC LLY | 10 | $1,126 |
| Amgen Inc. AMGN | 7 | $124 |
| Novo Nordisk Inc NVO | 6 | $108 |
| Abbvie Inc. ABBV | 4 | $69.05 |
| Insulet Corporation PODD | 3 | $54.76 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $53.61 |
| Xeris Pharmaceuticals, Inc. | 2 | $35.06 |
| Madrigal Pharmaceuticals MDGL | 2 | $30.99 |
| CeQur Corporation | 1 | $17.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.